Conversely, a previous study reported that BACE1 inhibitor treatment repairs pathophysiology and cognitive deficits in APP23xPS45 mice even when initiated after the development of extensive Aβ pathology [49]. The gene discussed is BACE1; the disease is Cognitive impairment.